Navigation Links
Men Might Get Their Share of Cervical Cancer Vaccine As Well

The first ever-cervical cancer vaccine, Gardasil is expected to be launched in New Zealand soon, targeting females between 9 and 24 years of age. // Soon, men might also be given cervical cancer vaccines to prevent them from infecting their sexual partners and to protect themselves against several diseases.

The vaccine is currently under experimental phase, for demonstration of cervical cancer prevention. Most cases of cervical cancer can be attributed to human papilloma virus infection (HPV), spread through sexual contact. An association between the virus and anal cancer has also been observed, consistent with high reports of infection among gay men.

Previous vaccine trials had demonstrated the increase in antibody production against the four target HPV types, known to cause cancer and genital warts in both men and women. There could be a 70% reduction in the cervical cancer incidence if the vaccine is found to be effective in preventing HPV associated cervical cancers.

It has been found form numerous studies that 80% of the population is exposed to HPV at some point during their lifetime. A majority of this goes unnoticed, as there are no symptoms. The immune system may be effective in getting rid of the virus. A small group of people however develop persistent infections.

The effectiveness of the vaccine would be more relevant when it is administered before onset of sexual activity. Taking this fact into account, the ideal age for administration of the vaccine is considered to be 11 years. If approved for use, it can be incorporated as the last of injections on the national immunization schedule.

Cervical cancer represents a major health care burden haunting women. This may be the focus for increased clinical trials in women when compared to the poor attention given to prevention of HPV-linked cancers in men. However, large clinical trials involving men are being conducted, the results of which would be released in three years time.

In line with these clinical trials, GlaxoSmithKline is also testing a potential HPV vaccine. With such healthy competition among several pharmaceutical companies, we might perhaps soon put an end to the misery and suffering associated with at least one form of cancer.


'"/>




Related medicine news :

1. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
2. Tomatoes Might Inhibit the Development Of Prostate Cancer
3. Mad Cow Disease Might Be Linked to Blood Transfusions
4. Strategies That Might Lower Blood Pressure Questioned
5. Factors That Might Increase The Risk Of Schizophrenia
6. A Drug That Might Relieve Chronic Cough
7. Biochemical Markers Might Help Predict Heart Problems
8. Yoga Might Be Helpful For Cancer Patients
9. Healthcare Professionals Might Want To Rethink Their Dress Code
10. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
11. Counting Calories Might Be The Ideal Way To Stay Healthy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... March 23, 2017 , ... Benefits ... an innovative mobile app and centralized benefits dashboard solving one of the top ... from multiple locations. For the first time, employees can access up-to-date information and ...
(Date:3/23/2017)... ... March 23, 2017 , ... Michael Lanteri ... the greater Fort Collins area, has unveiled a collaboration with nonprofit Big Bones ... Donations to this worthy cause may now be made at http://bigbonescaninerescue.com/ . ...
(Date:3/23/2017)... Fla. (PRWEB) , ... March 23, 2017 , ... ... transforming healthcare for seniors, today announced rapid completion of the strategic executive team ... announce several notable additions to the ChenMed executive team,” says Christopher Chen, MD, ...
(Date:3/23/2017)... ... March 23, 2017 , ... Inflow IQ & Inflownomics ... serious so build on a solid foundation. As experts in dangerous situations the ... that is coming soon. Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems that ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... awarded Task Force Dagger Foundation the US Special Operations Command’s Patriot Award. The ... presentation, General Thomas thanked Task Force Dagger Foundation for its significant and enduring ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017  Ethicon* today announced ... Inc., a privately held medical device company that ... for the surgical treatment of Gastroesophageal Reflux Disease ... of expanding its portfolio of minimally invasive options ... conditions. Financial terms of the transaction have not ...
(Date:3/23/2017)... , March 23, 2017  Additive Orthopaedics, ... announced that it has kicked off a multi-centered ... 3D printed bone segments. According to ... unique variable honeycomb lattice structures have already shown ... compared to current allograft wedges from which we ...
(Date:3/23/2017)... 23, 2017 Ascendis Pharma A/S (Nasdaq: ASND), ... to address significant unmet medical needs in rare diseases, ... call and webcast on Monday, April 3 during ENDO ... Orlando, Florida , to discuss new ... Growth Hormone, TransCon PTH and TransCon CNP). ...
Breaking Medicine Technology: